Co-Diagnostics sets Sept. 30 meeting after two adjournments
Previously submitted valid proxies remain in force for the September 30 meeting unless properly changed or revoked before votes are taken.
Rhea-AI Filing Summary
Co-Diagnostics, Inc. adjourned its annual meeting after it failed to achieve a quorum on September 3 and again on September 24, 2026. The reconvened meeting is scheduled for September 30, 2026, at 9:00 a.m. Mountain Time at the company’s offices in Salt Lake City. Stockholders will vote as described in the definitive proxy statement, and valid proxies submitted before the reconvened meeting remain effective unless properly changed or revoked before votes are taken.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Terms
quorum, adjourned, valid proxies
3 terms
quorum regulatory
"did not achieve a quorum"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
adjourned regulatory
"the Annual Meeting was again adjourned"
Adjourned means a meeting, hearing, trading session or official proceeding has been paused or suspended and will be continued at a later time or date. For investors this matters because an adjournment delays decisions or announcements that can affect prices or strategy, like postponing a verdict or board vote; it’s like pausing a game until players can reconvene, giving more time for information or planning.
valid proxies regulatory
"Valid proxies submitted prior to the reconvened Annual Meeting"
Valid proxies are ballots or written authorizations that shareholders submit to vote on corporate matters that meet legal and company rules, meaning they are signed, dated, and cast in the proper form and timeframe. They matter to investors because these accepted votes determine control over decisions like electing directors or approving deals — like a signed permission slip that actually counts, with the power to change company strategy and potentially affect the stock price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
